Learn more

FUNDACAO BUTANTAN

Overview
  • Total Patents
    24
About

FUNDACAO BUTANTAN has a total of 24 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Brazil, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AMPHERA B V, VIRTTU BIOLOGICS LTD and TERMAN DAVID S.

Patent filings in countries

World map showing FUNDACAO BUTANTANs patent filings in countries

Patent filings per year

Chart showing FUNDACAO BUTANTANs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Raw Isaias 14
#2 Furuyama Noemi 4
#3 Sakauchi Maria Aparecida 4
#4 Kubrusly Flavia Saldanha 4
#5 Dias Waldely De Oliveira 3
#6 Ho Paulo Lee 3
#7 Tanizaki Martha Massako 3
#8 Higashi Hisako Gondo 3
#9 Horton Denise Silvina Piccini 3
#10 Quintilio Wagner 3

Latest patents

Publication Filing date Title
US2015240230A1 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique
BR102012003790A2 Recombinant mycobacterium cepa, immunogenic composition and use
WO2012040806A2 Synergistic immunogenic compositions based on protein antigens combined with pertussis cell antigen and inactivated toxins
BRPI0904528A2 method of conjugating capsular polysaccharide to a carrier protein for use as a vaccine antigen against encapsulated bacteria using 4- (4,6-dimethoxy-1,3,5-triazin-2-yl) -4-methylmorpholine chloride reagent (dmt-mm)
WO2008134830A1 Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production
WO2006002502A1 Process for obtention of new cellular pertussis vaccine
BRPI0403855A capsular polysaccharide purification process of pathogenic microorganisms for vaccine production
BRPI0402984A method of obtaining a capsular polysaccharide and protein conjugate resulting in a covalent polysaccharide protein compound for use as a vaccine antigen
BRPI0400341A Process for obtaining purified bhk-21 cell rabies vaccine for veterinary use and its resulting vaccine
BR0202458A Process for obtaining acellular pertussis vaccine
BR0006798A Humanization process of the complementary dna (cdna) of bovine fibrolasto-2 (fgf-2) growth factor, its product expressed in escherichia coli, and therapeutic use of that product
BR0004568A Bivalent conjugate vaccine against meningitis types "b" and "c", and the respective process for obtaining it
BR9900436A Process for obtaining exogenous natural pulmonary surfactant of swine origin, and resulting product
BR9900437A Erythropoietin purification process
BR9601749A Use of tangential ultrafiltration for the elimination of lipopolysaccharide during the purification process of capsular polysaccharide from gram negative bacteria
BR9505983A Recombinant plasmid for use in the production of hepatitis B vaccine
BR9505982A Production of peptides from tityus bahienses and tityus stigmurus scorpions and their use in the umunization of horses in order to obtain anti-scorpion serum
BR9403020A Cloning expression and use of toxins from the venom gland of the coral snake "Micrurus corallinus"
BR9103064A Test to detect choleric vibration